Evidence map›Paper›PMID 28438918›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2017

Does the impact of biodiversity differ between emerging and endemic pathogens? The need to separate the concepts of hazard and risk.

Parviez R Hosseini, James N Mills, Anne-Hélène Prieur-Richard, Vanessa O Ezenwa, Xavier Bailly, Annapaola Rizzoli, Gerardo Suzán, Marion Vittecoq, Gabriel E García-Peña, Peter Daszak and 2 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Wildlife susceptibility to infectious diseases at global scales.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 5 countries.

Parviez R HosseiniEcoHealth Alliance, 460 West 34th Street - 17th Floor, New York, NY 10001-2320, USA parviez.hosseini@gmail.com.
James N MillsPopulation Biology, Ecology, and Evolution Program, Emory University, 1335 Springdale Road, Northeast, Atlanta, GA 30306, USA.
Anne-Hélène Prieur-RichardUnited Nations Environmental Programme, FutureEarth Programme, Montreal, Quebec, Canada.
Vanessa O EzenwaOdum School of Ecology and Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, 140 East Green Street, Athens, GA 30602-2202, USA.ORCID http://orcid.org/0000-0002-8078-1913
Xavier BaillyINRA, UR346 Epidémiologie Animale, 63122 Saint Genès Champanelle, France.
Annapaola RizzoliEdmund Mach Foundation, Research and Innovation Centre, 1 Via Edmondo Mach, 38010 San Michele all'Adige, Trentino, Italy.
Gerardo SuzánDepartamento de Etología y Fauna Silvestre, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Distrito Federal, C.P. 04510, Mexico.
Marion VittecoqCentre de recherche de la Tour du Valat, Le Sambuc, 13200 Arles, France.
Gabriel E García-PeñaDepartamento de Etología y Fauna Silvestre, Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Ciudad Universitaria, Distrito Federal, C.P. 04510, Mexico.ORCID http://orcid.org/0000-0002-3515-6908
Peter DaszakEcoHealth Alliance, 460 West 34th Street - 17th Floor, New York, NY 10001-2320, USA.
Jean-François GuéganUMR MIVEGEC CNRS 5290/IRD 224/Université de Montpellier, 911 avenue Agropolis, BP 64501, 34394 Montpellier Cedex 5, France.
Benjamin RocheUMI IRD/UPMC 209 UMMISCO, 32, avenue Henri Varagnat, 93143 Bondy Cedex, France benjamin.roche@ird.fr.ORCID http://orcid.org/0000-0001-7975-4232
Centre National de la Recherche Scientifique · FRFuture Earth · CAEcoHealth Alliance · USEmory University · USÉpidémiologie des maladies Animales et zoonotiques · FRFondazione Edmund Mach · ITSorbonne Université · FRTour du Valat · FRUniversidad Nacional Autónoma de México · MXUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biodiversity is of critical value to human societies, but recent evidence that biodiversity may mitigate infectious-disease risk has sparked controversy among researchers. The majority of work on this topic has focused on direct assessments of the relationship between biodiversity and endemic-pathogen prevalence, without disentangling intervening mechanisms; thus study outcomes often differ, fuelling more debate. Here, we suggest two critical changes to the approach researchers take to understanding relationships between infectious disease, both endemic and emerging, and biodiversity that may help clarify sources of controversy. First, the distinct concepts of hazards versus risks need to be separated to determine how biodiversity and its drivers may act differently on each. This distinction is particularly important since it illustrates that disease emergence drivers in humans could be quite different to the general relationship between biodiversity and transmission of endemic pathogens. Second, the interactive relationship among biodiversity, anthropogenic change and zoonotic disease risk, including both direct and indirect effects, needs to be recognized and accounted for. By carefully disentangling these interactions between humans' activities and pathogen circulation in wildlife, we suggest that conservation efforts could mitigate disease risks and hazards in novel ways that complement more typical disease control efforts.This article is part of the themed issue 'Conservation, biodiversity and infectious disease: scientific evidence and policy implications'.

Indexed as

BiodiversityAnimalsCommunicable Diseases, EmergingHumansPrevalenceProportional Hazards ModelsRiskZoonosesbiodiversityemerging infectious diseasehazardspathogenriskzoonotic

Identifiers

PMID28438918
PMCPMC5413877
OpenAlexW2609922265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.